Pfēnex Expression Technology Platform™

…assures the first time, significant production of virtually any aglycosylated protein in a scalable system within five weeks, enabling the rapid advancement of protein leads into proof-of-concept or clinical studies

…produces protein of high quality due to specific components of the platform being designed to ensure soluble and active expression through the avoidance of proteolytic clipping and post translational modifications along with enhancements to solubility through protein folding improvements

…has a rapid fermentation cycle time, utilizing a low cost defined medium with no animal-derived components, achieves high specific and volumetric expression titers, and leverages advantaged protein recovery technologies all resulting in the lowest cost of goods

….provides an economy of scale in the ability to be incorporated into virtually any fermentation scale-up system in use today

…is a lower risk platform due to acceptance by domestic and international regulatory agencies in multiple human clinical trials up to Phase 3 currently in process